Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sann-Joong-Kuey-Jian-Tang (SJKJT), also known as San-Zhong-Kui-Jian-Tang or Sanshu-kaigen-to, is a traditional Chinese medicine (TCM) herbal prescription consisting of 17 to 18 medicinal herbs, including Forsythia fruit, Laminaria leaf, and Scute root. It has been traditionally used to treat lymphadenopathy, swelling, and inflammation, and is utilized as a complementary or adjuvant medication for various solid cancers in Taiwan and other regions. Research indicates that SJKJT exhibits antineoplastic activity against several human cancer cell lines, including breast cancer, colon cancer, hepatocellular carcinoma, oral squamous cell carcinoma, and pancreatic cancer. Its molecular mechanisms of action include the dual blockade of the Ras/Raf/MEK/ERK and Ras/PI3K/Akt/mTOR pathways, down-regulation of growth factor receptors such as VEGFR, EGFR, and IGF-IR, and induction of cell cycle arrest and mitochondrial apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sann-Joong-Kuey-Jian-Tang.